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Abstract
Background
The Pacific Islands have environmental conditions highly favourable for transmission of lep-
tospirosis, a neglected zoonosis with highest incidence in the tropics, and Oceania in partic-
ular. Recent reports confirm the emergence and outbreaks of leptospirosis in the Pacific
Islands, but the epidemiology and drivers of transmission of human and animal leptospirosis
are poorly documented, especially in the more isolated and less developed islands.
Methodology/Principal findings
We conducted a systematic review of human and animal leptospirosis within 25 Pacific
Islands (PIs) in Polynesia, Melanesia, Micronesia, as well as Easter Island and Hawaii. We
performed a literature search using four international databases for articles published
between January 1947 and June 2017. We further included grey literature available on the
internet. We identified 148 studies describing leptospirosis epidemiology, but the number of
studies varied significantly between PIs. No data were available from four PIs. Human lepto-
spirosis has been reported from 13 PIs, with 63% of all studies conducted in Hawaii, French
Polynesia and New Caledonia. Animal leptospirosis has been investigated in 19 PIs and
from 14 host species, mainly pigs (18% of studies), cattle (16%) and dogs (11%). Only 13
studies provided information on both human and animal leptospirosis from the same loca-
tion. Serology results were highly diverse in the region, both in humans and animals.
Conclusions/Significance
Our study suggests that, as in other tropical regions, leptospirosis is widespread in the PIs
while showing some epidemiological heterogeneity. Data are scarce or absent from many
PIs. Rodents, cattle, pigs and dogs are all likely to be important carriers, but the relative
importance of each animal species in human infection needs to be clarified. Epidemiological
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surveys with appropriate sampling design, pathogen typing and data analysis are needed to
improve our understanding of transmission patterns and to develop effective intervention
strategies.
Author summary
Leptospirosis is an important bacterial zoonosis that affects people and animals world-
wide. It is common in tropical areas, especially in island ecosystems. Because islands are
relatively small, isolated, and have limited health and diagnostic facilities, the disease bur-
den is often underestimated. In this systematic review, we aimed to describe the extent of
leptospirosis in the Pacific Islands, including the diversity of pathogens and animal reser-
voirs. We identified 148 studies from 21 Pacific islands that described Leptospira infection
in humans or animals. In hospitalized febrile patients, leptospirosis was a common cause
of the acute febrile illness, but accurate diagnosis was challenging and often delayed
because symptoms overlapped with many other infectious diseases, and access to labora-
tory diagnosis was limited. A wide variety of animal hosts of Leptospira were identified,
with rodents, cattle, pigs and dogs reported as important hosts; however, their relative
importance in human infection remains unclear. Our review demonstrates that the epide-
miology of leptospirosis varies across the Pacific Islands, but information about risk fac-
tors and transmission routes is currently limited. We recommend more integrated
studies, using an eco-epidemiological approach that includes human, veterinary and envi-
ronmental factors, and interactions between factors at different ecological scales.
Introduction
Leptospira is a genus of bacteria belonging to the phylum of Spirochaetes causing leptospirosis
in humans and other mammals [1]. Leptospirosis is the most widespread and potentially fatal
bacterial zoonosis worldwide [2], with an estimated 1.03 million human cases and 58,900
deaths worldwide each year [3]. The majority of the disease burden occurs in tropical regions
where large epidemics can occur after heavy rainfall and flooding [4]. Leptospirosis is a
neglected disease in most of the tropics, especially in the Pacific region [5], and a recent sys-
tematic review found that Oceania was the region most impacted by leptospirosis in terms of
morbidity (150.68 cases per 100,000 per year), mortality (9.61 deaths per 100,000 per year) [3],
and disability adjusted life years (DALY) [6]. Incidence of up to 1,945 cases per 100,000 popu-
lation has been reported in 2008 in Futuna (a Polynesian island) during a multi-year outbreak
[7]. The health impacts of leptospirosis have been predominantly attributed to acute infections
and early complications such as pulmonary haemorrhage and renal failure. However, leptospi-
rosis can also cause subacute and chronic complications and long-term sequelae [8].
Two classification schemes are used for Leptospira, one based on serology with the serovar
as the basic taxon, and another which uses molecular taxonomy to identify the species, some-
times referred to as genomospecies [2]. Leptospira have been classified serologically into over
300 serovars grouped in almost 30 serogroups (both saprophytic and pathogenic) using Micro-
scopic Agglutination Test (MAT) and Cross Agglutination Absorption Test (CAAT) [9, 10].
Phylogenetically, the genus Leptospira is divided into 23 species based on 16S rRNA phylogeny
and DNA-DNA hybridization, and clustered into saprophytic, intermediate and pathogenic
groups [11]. Laboratory diagnosis of leptospirosis may be accomplished by direct detection of
A systematic review of human and animal leptospirosis in the Pacific Islands
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006503 May 14, 2018 2 / 32
the organism or its components in body fluid or tissues, by isolation of leptospires in cultures,
or by detection of specific antibodies [12, 13]. Molecular diagnosis is based on Leptospira DNA
amplification from serum, urine, aqueous humour, cerebrospinal fluid (CSF) or post-mortem
tissue samples [14]. Historically, most cases of leptospirosis have been diagnosed by serology,
because capacity for culture and PCR were limited. IgM antibodies are detectable in the blood
from 5–7 days after the onset of symptoms [2]. The use of agglutination tests was described
soon after the first isolation of the organism, and the MAT remains the definitive serological
investigation technique in both humans and animals [15].
Human infections range from, most commonly, a mild ‘flu-like illness, to severe complica-
tions including acute renal failure and pulmonary haemorrhagic syndrome associated with
high fatality rates. Infection results from direct or indirect exposure to urine from infected res-
ervoir host animals that carry the pathogen in their renal tubules and shed pathogenic lepto-
spires which contaminate soils, surface waters, streams and rivers [2]. Humans are infected via
mucous membranes, abrasions or cuts in the skin. Prolonged immersion in, or swallowing of,
contaminated water can also result in infection. Numerous animal species, including rodents
(often considered as the main reservoir), domestic mammals (including livestock and com-
panion animals) and wildlife, have been shown to be reservoirs for Leptospira [15]. In food-
producing animals, cattle and pigs are relatively susceptible to clinical infection, resulting in
production losses including reduced milk yield, reproductive failure, abortions, premature
birth or stillbirth [16].
The Oceania region includes Australia, New Zealand and the Pacific Islands Countries and
Territories (PICTs), these latter all falling within the tropics. Poverty, remoteness and tropical
climate all contribute to vulnerability to, and significant burden of, infectious diseases in the
PICTs [17]. Global emergence of leptospirosis has been associated with environmental factors
including rainfall, flooding, poverty, and urbanization [18–20], all of which are important
drivers of transmission in the Pacific Islands. Recent reports confirm the emergence of lepto-
spirosis in the Pacific region, with increase in incidence and reports of unprecedented out-
breaks [5, 21]. However, the incidence of leptospirosis is unfortunately not well-documented
from many Pacific Islands, mainly because of the unavailability of laboratory diagnosis [22,
23], poor medical awareness, and non-specific symptoms that overlap with many other tropi-
cal infectious diseases, especially arbovirus infections [24]. As a consequence, little is known
about the ecological, epidemiological and clinical characteristics of leptospirosis in the region,
and the burden of the disease might be even higher than recognized.
To tackle these gaps in current knowledge and understanding of human and animal lepto-
spirosis infection in the Pacific Islands, we conducted a systematic review of both peer-
reviewed and grey literature following the Preferred Reporting Items for Systematic Reviews
and Meta-analyses (PRISMA) guidelines [25]. Our aims were to summarise and compare
human and animal leptospirosis within and between the Pacific Islands.
Methods
Geographic scope
The selection of the countries and territories to be included in this review was based on the
official list of the United Nations Statistics Division for the geographical region #009 Oceania
(http://unstats.un.org/unsd/methods/m49/m49regin.htm#oceania). We excluded Australia
and New Zealand (#053) and focused on the small islands of the PICTs including five in Mela-
nesia (Fiji, New Caledonia, Papua New Guinea, Solomon Islands, Vanuatu), eight in Microne-
sia (Guam, Kiribati, Marshall Islands, Federated States of Micronesia, Nauru, Mariana Islands,
Palau, United States Minor Outlying Islands) and ten in Polynesia (American Samoa, Cook
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Islands, French Polynesia, Niue, Pitcairn Islands, Samoa, Tokelau, Tonga, Tuvalu, and Wallis
and Futuna). The “United States Minor Outlying Islands” were restricted to Wake Island in
our study. We further included Easter Island (Chile) as well as Hawaii (U.S.A.) (Fig 1). Except
for Papua New Guinea and Hawaii, the included PIs had populations of less than one million
inhabitants and represented significant diversity in economies, geography, culture and living
conditions. For ease of reference, the 25 countries and territories included in this review will
be referred to as ‘Pacific Islands’ (PIs).
Search strategy
Peer-reviewed studies were sought in June 2017 from four international databases (PubMed,
Web of Science, Scopus, and Embase (Ovid)) for resources published between January 1947
and June 2017 inclusively, either in English or in French, and following the PRISMA guide-
lines [25] (S1 Appendix). The search strategy is presented in detail in S2 Appendix. Secondly,
additional peer-reviewed studies were retrieved by examining the references from the papers
identified by the initial electronic search. Thirdly, grey literature (i.e. print and electronic for-
mats that have not been formally published by commercial publishers) were reviewed by scru-
tinising the websites of government health departments and other relevant administrative
Fig 1. Map of the South Pacific region. All countries in Oceania were included in this review with the exception of Australia and New Zealand. Easter Island does not
appear on the map but was included in our study. ‘W&F’: Wallis and Futuna. ‘Am.Sam.’: American Samoa. The map was provided by the Pacific Community (SPC) and
is available online at: http://pacific.popgis.spc.int.
https://doi.org/10.1371/journal.pntd.0006503.g001
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bodies of the Pacific Islands (see S2 Appendix for the list of websites browsed), and by bibliog-
raphy hand searches of relevant articles from Google Scholar (https://scholar.google.com).
Eligibility criteria
Inclusion criteria. A publication was included in this review if it contained qualitative
and/or quantitative information on human or/and animal leptospirosis in the PIs, including
environmental studies, case reports, outbreak description or epidemiologic surveys. Confer-
ence papers were included if they contained relevant information not published in a peer-
reviewed journal.
Exclusion criteria for title and abstract review. Reviews or summary articles, editorials,
letters to the editor, opinions or commentaries without original data were excluded, as well as
lay media publications or broadcasts. We further excluded publications focusing on (i) the
wrong geographic location, (ii) the wrong agent/disease, (iii) experimental data (in vitro or in
vivo cellular, molecular, biochemical or other studies that did not include naturally occurring
cases of leptospirosis in humans or animals), and (iv) descriptions or studies of laboratory
methods. The inclusion and exclusion criteria were applied to the title and abstract of all
retrieved references. References for which no abstract was available were included in the next
stage of full text review.
Exclusion criteria during full-text review. The full texts of articles classified as eligible
for inclusion were retrieved and assessed against the same exclusion criteria as per abstract
review. Any articles where the country was not specified were excluded, as well as references
for which the methods or study population were not described in sufficient detail to determine
whether the study met inclusion or exclusion criteria. When more than one reference was
retrieved for the same study, or when the same data were retrieved under different formats
(publications, project reports, conference presentation), only the most comprehensive one was
retained. We included reports of returned travellers despite a potential uncertainty around the
specific location where infection was acquired, because for some of the Pacific Islands consid-
ered, this was the only information/evidence available. Studies for which the full text was not
available were excluded except when relevant data (qualitative or quantitative) were available
from the abstract or from a later published study.
Data collection process
The data collection process was undertaken in two steps. First, abstracts and titles were com-
piled in EndNote (Thomson Reuters, Philadelphia, PA, USA) and reviewed by one researcher
(VG) on the basis of the abstract and title. Second, the articles identified through the pre-selec-
tion process were retrieved in full text format and reviewed independently by two researchers
for the full text (VG and either CG, JB or CLL). A third researcher served as a tiebreaker for
any discordant decisions.
Following the inclusion/exclusion process, qualitative and quantitative data were extracted
from each of the included articles. Papers were classified into human clinical studies, human
community-based studies, and animal population studies (no animal clinical studies were
identified). For human studies, information was compiled on the country, year(s) of study,
study design, target population, inclusion criteria, number enrolled, diagnostic tests used, con-
firmed leptospirosis cases and risk factors. For animal studies, information was compiled on
country, year(s) of study, species investigated, methodology, number of samples, and con-
firmed positivity for Leptospira. When available, data on serology and genetic typing of isolates
from humans and animals were also compiled and summarised by country and by animal
species.
A systematic review of human and animal leptospirosis in the Pacific Islands
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006503 May 14, 2018 5 / 32
Case definition and strength of evidence of results
MAT is a serogroup-specific assay and does not provide reliable information on the infecting
serovar [26, 27]; results were therefore summarised at the serogroup level even if studies
reported MAT results at the serovar level. Although serogroups are no longer used in the taxo-
nomic classification of serovars, they remain useful for laboratory purposes and epidemiologi-
cal comparisons.
As the definition of a “positive” serology result differed between studies, we standardised
results across the studies by using the following case definitions:
1. For the human clinical studies, a confirmed case was defined based on the recommenda-
tions of the WHO LERG report [28] as follows: clinical signs and symptoms consistent with
leptospirosis and one or more of the following: (i) positive PCR or isolation by culture; (ii)
seroconversion or fourfold increase in MAT titre between acute and convalescent serum
samples; (iii) MAT titre 1:400 in single serum sample. Cases that fitted the confirmed
case definition were considered “strong evidence” whereas others were considered “weak
evidence”.
2. For the seroprevalence studies (human or animal), any positive MAT result (as defined by
the individual studies, from 1:50 upwards) was considered to indicate previous infection.
However, opportunistic sampling of animals with less than ten individuals of a species was
considered as “weak evidence”.
3. Any result based on Leptospira isolates was considered “strong evidence”.
When MAT results were detailed, the serogroup with the highest titre was reported as puta-
tively involved. If equally high titres were reported for more than one serogroup, MAT was
considered positive but serogroup results were not reported. If data were not detailed enough
to allow interpretation (especially in the case of cross-reactions), serogroup results were not
reported.
Critical assessment of data quality and possible bias
Because of the great heterogeneity in the methodology and the quality of the data between
studies, most of the data reported in our review are qualitative rather than quantitative. As
detailed in the previous paragraph, methodological quality was assessed for serology studies by
comparison to pre-determined case definition criteria to control for heterogeneity in study
design and diagnostic methodology. Evidence of Leptospira infection was assessed for each
study as ‘strong’ or ‘weak’. The sample sizes (number of animal tested, number of clinical cases
reported) are reported in our review when necessary, as an indication of the degree of confi-
dence of the results. Exposure and risk factors are reported as per the included studies, and are
considered mostly as untested hypotheses. Epidemiological studies providing risk factors
based on robust analyses are highlighted.
Results
Selected studies
The initial search retrieved a total of 675 studies, including 386 on PubMed, 68 on Scopus, 68
on Web of Science, and 153 on Embase respectively. After removing 205 duplicates, 103 met
the inclusion and exclusion criteria. A further 44 studies were identified, either from the refer-
ence list of already included papers (n = 15), or when searching internet websites for grey liter-
ature (n = 29). One publication from the last author of the present review (CL) that was
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accepted for publication after the search in June was also added, making a final list of 148 stud-
ies. For 11 studies, the full text document could not be retrieved but quantitative and/or quali-
tative data were available from the abstract, or from the full text of later published papers. The
flow diagram of the search strategy is summarised in Fig 2.
The included leptospirosis studies were conducted in 21 out of the 25 PIs within the scope
of our study. No information about leptospirosis was retrieved from Nauru, Pitcairn Islands,
Tuvalu and Wake Island. Included studies were mostly either dedicated to animals (n = 54,
36.5%) or humans (n = 79, 53.4%), while very few studies (n = 13, 8.7%) provided information
Fig 2. Flow diagram of the systematic review and identification of studies. Among the 148 included studies, 11 full
texts could not be retrieved but quantitative and/or qualitative data were collected from the abstract or from the full
text of later published studies.
https://doi.org/10.1371/journal.pntd.0006503.g002
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on both animals and humans. The remaining two studies (1.4%) focused on Leptospira in the
environment [29, 30]. Detailed information on each study is provided in S1 Table.
Human leptospirosis studies
Human leptospirosis was investigated in 92 eligible studies from 14 PIs. We classified human
studies into two categories: community-based studies (investigating healthy people) and clini-
cal studies (investigating people who were unwell) (see Fig 3 and S1 Table). Community-based
studies consisted of 19 (21%) seroprevalence studies, of which six were “mixed” studies that
also included clinical case reports. The remaining 73 studies (79%) were clinical, including sur-
veillance data, case reports or leptospirosis investigation in sick and/or hospitalised patients).
Clinical studies were reported as strong or weak evidence of leptospirosis following the criteria
detailed in the methods section (see S1 Table for detailed classification). French Polynesia was
the most frequently represented PI with a total of 22 studies [5, 24, 31–48], followed by 20
Fig 3. Number of studies that reported Leptospira infection from humans and/or animals in the Pacific Islands (PIs). Empty cells correspond to PIs/species for
which no studies were retrieved; coloured cells and numbers correspond to PIs/species for which studies were retrieved, and the number of studies included in this
review. The presence or absence of Leptospira is reported in yellow or grey respectively. For animal studies that provided no evidence of Leptospira infection, the number
of tested animals is given in brackets to provide an indication of the degree of confidence of the negative results. Similarly, when only one human clinical study was
conducted in a specific PI, the number of reported cases is given in brackets. a Federated States of Micronesia; b Wake Island is part of the United States Minor Outlying
Islands. ‘Pop’: July 2016 estimated population size reported from the CIA World Factbook (https://www.cia.gov/library/) except for Hawaii, Wake Island and Easter
Island for which data were retrieved from different internet sources. ‘Comm. studies’: human community-based studies. ‘’: includes one study on feral pigs. ‘?’:
inconclusive results (reported from [85]).
https://doi.org/10.1371/journal.pntd.0006503.g003
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from New Caledonia [32, 36, 42, 49–65] and 19 from Hawaii [66–84]. Of the 14 PIs investi-
gated, confirmed cases were reported from 13 PIs only as four suspected leptospirosis cases
investigated in Tonga were later reported as negative [5].
Animal leptospirosis studies
Past infection with, or renal carriage of, leptospires in animals was investigated in 66 eligible
studies from 19 PIs, plus one paper that reported animal leptospirosis from 22 PIs [85] (S1
Table). In total, 13 different animal species were tested: bandicoots (Echymipera kalubu), cats
(Felis catus), cattle (Bos spp.), deer (Rusa timorensis), dogs (Canis lupus), pigs (Sus scrofa),
goats (Capra aegagrus), horses (Equus ferus), mongooses (Herpestes auropunctatus), mice (Mus
musculus), rats (Rattus spp.), sheep (Ovis aries), and in one case, Hawaiian monkey seals (Mon-
achus schauinslandi). Both feral and farmed populations of pigs and deer were investigated.
Livestock represented the majority of the investigations, i.e. farmed pigs (29 studies from 18
PIs) and cattle (27 studies from 14 PIs), followed by rats (28 studies from 8 PIs) and domestic
dogs (24 studies from 9 PIs).
The majority of animal studies (n = 54, 82%) were seroprevalence studies. Renal carriage
was also investigated (n = 14, 21%) especially in rats, either alone or in combination with serol-
ogy. Older studies reported the presence of leptospires in kidneys from microscopic examina-
tion of tissues or by experimental infection of guinea pigs (e.g. by injection of crushed rat
kidneys), while more recent studies used real-time PCR for confirmation of infection. Evi-
dence of past or present Leptospira infection was most commonly found in farmed pigs (27
studies from 15 PIs) followed by cattle (24 studies from 13 PIs), rats (24 studies from 8 PIs)
and dogs (22 studies from 9 PIs) (Fig 3). There was variation in the sample sizes between stud-
ies, ranging from one animal tested in some studies that reported on opportunistic sampling
of animals to about 9,000 animals in a study of cattle in the Solomon Islands [86].
Serology results by serogroup
Studies reported a total of 21 putative Leptospira serogroups in humans or animals across the
Pacific, the most common being Icterohaemorrhagiae (15 PIs), Pomona (15 PIs), Australis (14
PIs) and Sejroe (13 PIs). Table 1 summarises the serogroups reported for humans and animal
species for each PI. However, this finding should be interpreted with caution because of the
many limitations of the MAT, including cross-reactions between serovars and serogroups, par-
adoxical reactions or anamnestic responses [2, 87]. MAT results might also vary depending on
the panel of serovars used.
Hawaii
Human leptospirosis was recognised as early as 1936 in Hawaii; seroprevalence studies investi-
gated the general population in Honolulu [66] and sugar cane workers [67] in 1936–1942, and
revealed seroprevalence rates of 3.8% (13/344) and 12.2% (105/860) respectively, using a cut-
off titre of 1:100. A seroprevalence study of US army blood bank donors conducted in 2002 in
Oahu found a positivity rate of 1.4% (7/488) [79]. Sixteen publications reported leptospirosis
cases from surveillance data and clinical studies between 1962 and 2008. Information by island
was not always available as surveillance data generally included cases from all islands, but a few
studies were dedicated to Kauai and Oahu, reporting sporadic cases. One study investigated
cases of leptospirosis during an outbreak of murine typhus on Kauai (1998) and reported two
cases of co-infection with both diseases [76]. The complete list of human studies from Hawaii
is reported in Table 2.
A systematic review of human and animal leptospirosis in the Pacific Islands
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006503 May 14, 2018 9 / 32
T
a
b
le
1
.
S
u
m
m
a
ry
o
f
se
ro
lo
g
y
re
su
lt
s.
R
es
u
lt
s
ar
e
re
p
o
rt
ed
at
th
e
se
ro
g
ro
u
p
le
v
el
.H
u
m
an
st
u
d
ie
s
in
cl
u
d
e
b
o
th
cl
in
ic
al
an
d
se
ro
p
re
v
al
en
ce
st
u
d
ie
s,
w
h
il
e
an
im
al
st
u
d
ie
s
ar
e
se
ro
p
re
v
al
en
ce
o
n
ly
.A
sp
e-
ci
fi
c
se
ro
g
ro
u
p
is
re
p
o
rt
ed
as
p
re
se
n
t
in
a
P
I
if
it
w
as
re
p
o
rt
ed
fr
o
m
at
le
as
t
o
n
e
st
u
d
y
o
v
er
th
e
1
9
4
7
–
2
0
1
7
p
er
io
d
,m
ea
n
in
g
th
at
st
u
d
ie
s
cl
as
si
fi
ed
as
‘w
ea
k
ev
id
en
ce
’f
o
r
le
p
to
sp
ir
o
si
s
w
er
e
al
so
in
cl
u
d
ed
.
F
o
r
th
is
re
as
o
n
,a
n
d
b
ec
au
se
o
f
th
e
li
m
it
at
io
n
s
o
f
th
e
M
A
T
,r
es
u
lt
s
sh
o
u
ld
b
e
in
te
rp
re
te
d
w
it
h
ca
u
ti
o
n
.
P
a
ci
fi
c
Is
la
n
d
s
(P
Is
)
S
er
o
g
ro
u
p
s
A
u
st
ra
li
s
A
u
tu
m
n
a
li
s
B
a
ll
u
m
B
a
ta
v
ia
e
C
a
n
ic
o
la
C
el
le
d
o
n
i
C
y
n
o
p
te
ri
D
ja
si
m
a
n
G
ri
p
p
o
ty
p
h
o
sa
H
eb
d
o
m
a
d
is
Ic
te
ro
h
a
em
o
rr
h
a
g
ia
e
Ja
v
a
n
ic
a
M
in
i
P
a
n
a
m
a
P
o
m
o
n
a
P
y
ro
g
en
es
S
a
n
ta
ro
sa
i
S
a
rm
in
S
ej
ro
e
S
h
er
m
a
n
i
T
a
ra
ss
o
v
i
M
el
a
n
es
ia
F
ij
i
h
u
m
an
✔
✔
✔
✔
✔
✔
✔
✔
an
im
al
m
ic
e,
ca
tt
le
,
g
o
at
,
ra
t,
m
o
n
g
o
o
se
,
p
ig
,
sh
ee
p
,
ca
tt
le
,
d
o
g
,
ra
t,
h
o
rs
e
m
ic
e,
p
ig
,
sh
ee
p
,
ca
tt
le
,
g
o
at
,
ra
t,
m
o
n
g
o
o
se
,
h
o
rs
e,
d
o
g
ca
tt
le
,
p
ig
,
h
o
rs
e,
d
o
g
,
m
ic
e,
m
o
n
g
o
o
se
ca
tt
le
,
g
o
at
,
ra
t,
h
o
rs
e
ca
tt
le
,
h
o
rs
e,
d
o
g
,
p
ig
p
ig
,
h
o
rs
e
ca
tt
le
,
p
ig
,
h
o
rs
e
ca
tt
le
,
p
ig
,
h
o
rs
e
ca
tt
le
,
m
o
n
g
o
o
se
ca
tt
le
,
g
o
at
,
p
ig
,
h
o
rs
e,
d
o
g
,
ra
t
p
ig
ca
tt
le
,
m
o
n
g
o
o
se
ca
tt
le
p
ig
,
g
o
at
,
ca
tt
le
,
h
o
rs
e
ca
tt
le
,
g
o
at
,
p
ig
,
h
o
rs
e,
d
o
g
ca
tt
le
p
ig
,
h
o
rs
e
ca
tt
le
,
g
o
at
,
p
ig
,
h
o
rs
e,
m
o
n
g
o
o
se
ca
tt
le
,
h
o
rs
e,
d
o
g
N
ew
C
al
ed
o
n
ia
h
u
m
an
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
an
im
al
ca
tt
le
,
d
ee
r,
h
o
rs
e,
d
o
g
ca
tt
le
,
d
ee
r,
h
o
rs
e,
d
o
g
ca
tt
le
,
d
ee
r,
h
o
rs
e,
d
o
g
,
ca
t
ca
tt
le
,
d
ee
r,
ca
t
ca
tt
le
,
d
ee
r,
h
o
rs
e,
d
o
g
,
ca
t
ca
tt
le
,
d
ee
r,
h
o
rs
e,
d
o
g
,
ca
t
ra
t,
ca
tt
le
,
p
ig
,
d
ee
r,
h
o
rs
e,
d
o
g
,
ca
t
ca
tt
le
,
h
o
rs
e,
ca
t
p
ig
,
d
ee
r,
h
o
rs
e
ca
tt
le
,
h
o
rs
e,
d
o
g
p
ig
,
ca
tt
le
,
d
ee
r,
d
o
g
ca
tt
le
,
d
ee
r
P
ap
u
a
N
ew
G
u
in
ea
h
u
m
an
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
an
im
al
d
o
g
,
p
ig
,
g
o
at
,
ra
t,
ca
tt
le
,
b
an
d
ic
o
o
t
d
o
g
,
p
ig
,
g
o
at
,
ra
t
g
o
at
,
ca
tt
le
,
h
o
rs
e
ra
t,
d
o
g
,
p
ig
,
g
o
at
,
h
o
rs
e
d
o
g
,
p
ig
d
o
g
,
p
ig
d
o
g
,
p
ig
,
h
o
rs
e,
ra
t
d
o
g
,
p
ig
,
ra
t,
ca
tt
le
d
o
g
,
p
ig
,
ra
t
d
o
g
,
p
ig
,
ra
t,
ca
tt
le
d
o
g
,
p
ig
,
g
o
at
,
ra
t,
ca
tt
le
d
o
g
,
p
ig
,
b
an
d
ic
o
o
t
d
o
g
,
p
ig
,
ca
tt
le
,
h
o
rs
e,
ra
t
d
o
g
,
p
ig
,
ca
tt
le
,
h
o
rs
e,
ra
t,
b
an
d
ic
o
o
t
S
o
lo
m
o
n
Is
.
an
im
al
ca
tt
le
,
p
ig
,
h
o
rs
e
ca
tt
le
ca
tt
le
,
h
o
rs
e
ca
tt
le
,
p
ig
p
ig
ca
tt
le
,
g
o
at
,
h
o
rs
e
ca
tt
le
,
h
o
rs
e
V
an
u
at
u
h
u
m
an
✔
✔
✔
✔
✔
an
im
al
ca
tt
le
ca
tt
le
ca
tt
le
ca
tt
le
M
ic
ro
n
es
ia
G
u
am
an
im
al
fe
ra
l
p
ig
fe
ra
l
p
ig
,
d
o
g
fe
ra
l
p
ig
fe
ra
l
p
ig
K
ir
ib
at
i
an
im
al
p
ig
?
g
o
at
,
p
ig
?
g
o
at
g
o
at
F
S
M
h
u
m
an
✔
✔
✔
✔
an
im
al
d
o
g
,
ra
t,
p
ig
ra
t,
p
ig
p
ig
p
ig
p
ig
p
ig
p
ig
d
o
g
,
p
ig
p
ig
p
ig
p
ig
p
ig
d
o
g
P
al
au
h
u
m
an
✔
✔
an
im
al
g
o
at
p
ig
p
ig
p
ig
p
ig
p
ig
p
ig
p
ig
g
o
at
,
p
ig
ca
tt
le
,
p
ig
p
ig
P
o
ly
n
es
ia
A
m
er
ic
an
S
am
o
a
h
u
m
an
✔
✔
✔
✔
✔
✔
an
im
al
ra
t?
d
o
g
d
o
g
C
o
o
k
Is
.
an
im
al
p
ig
ca
tt
le
ca
tt
le
F
re
n
ch
P
o
ly
n
es
ia
h
u
m
an
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
an
im
al
ca
tt
le
,
p
ig
,
h
o
rs
e
ca
tt
le
,
p
ig
ca
tt
le
,
p
ig
p
ig
p
ig
ca
tt
le
ca
tt
le
,
p
ig
,
h
o
rs
e
ca
tt
le
,
p
ig
,
h
o
rs
e
ca
tt
le
ca
tt
le
,
p
ig
H
aw
ai
i
h
u
m
an
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
an
im
al
m
o
n
g
o
o
se
,
fe
ra
l
p
ig
,
ra
t,
ca
tt
le
,
H
M
S
fe
ra
l
p
ig
ra
t,
m
ic
e,
m
o
n
g
o
o
se
ca
tt
le
m
o
n
g
o
o
se
fe
ra
l
p
ig
fe
ra
l
p
ig
ra
t,
fe
ra
l
p
ig
,
m
o
n
g
o
o
se
,
m
ic
e,
H
M
S
fe
ra
l
p
ig
fe
ra
l
p
ig
,
H
M
S
fe
ra
l
p
ig
ca
tt
le
,
H
M
S
,
ra
t,
m
ic
e,
m
o
n
g
o
o
se
T
o
k
el
au
an
im
al
p
ig
p
ig
T
o
n
g
a
an
im
al
p
ig
ca
tt
le
ca
tt
le
p
ig
ca
tt
le
,
p
ig
ca
tt
le
ca
tt
le
W
al
li
s
an
d
F
u
tu
n
a
h
u
m
an
✔
✔
✔
✔
an
im
al
d
o
g
,
p
ig
d
o
g
,
p
ig
d
o
g
,
p
ig
d
o
g
d
o
g
,
p
ig
d
o
g
,
p
ig
p
ig
d
o
g
,
p
ig
p
ig
p
ig
p
ig
S
am
o
a
an
im
al
ca
tt
le
,
h
o
rs
e,
p
ig
ca
tt
le
,
p
ig
ca
tt
le
,
p
ig
h
o
rs
e,
p
ig
ca
tt
le
,
h
o
rs
e,
p
ig
h
o
rs
e,
p
ig
p
ig
ca
tt
le
,
h
o
rs
e
ca
tt
le
,
h
o
rs
e,
p
ig
ca
tt
le
,
h
o
rs
e
ca
tt
le
,
h
o
rs
e,
p
ig
ca
tt
le
,
h
o
rs
e
ca
tt
le
,
p
ig
ca
tt
le
,
h
o
rs
e,
p
ig
ca
tt
le
,
p
ig
ca
tt
le
ca
tt
le
,
p
ig
h
tt
p
s:
//
d
o
i.o
rg
/1
0
.1
3
7
1
/jo
u
rn
al
.p
n
td
.0
0
0
6
5
0
3
.t
0
0
1
A systematic review of human and animal leptospirosis in the Pacific Islands
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006503 May 14, 2018 10 / 32
In Hawaii, the epidemiology and relative importance of risk factors for human leptospirosis
have evolved over the past few decades. Leptospirosis in Hawaii has historically been consid-
ered an occupationally-acquired disease affecting primarily sugarcane labourers and farmers,
but a shifting trend in exposure has been observed since the 1970s, with increasing importance
Table 2. Summary of publications reporting human leptospirosis in Hawaii, 1947–2017.
Citation Study
years
Case reports Seroprevalence studies Exposure/risk factors
[66] 1936–
42
Hawaii: 59 cases; Kanai: 4
cases; Lanai: 14 cases;
Maui: 1; Oahu: 4
Honolulu residents: 13/
344 (3.8%)
N/A
[67] 1943? Workers from sugar cane
plantations: 105/860
(13.0%)
Outdoor work, field work; heavy
rainfall
[68] 1962–
63
3 cases Exposure: Waded barefoot in a creek
[69] 1960–
75
Hawaii: 100 cases; Oahu:
21 cases; Kauai: 7 cases; 19
cases hospitalized
N/A
[70] 1970–
84
186 confirmed cases Prior to 1950: occupational risk (sugar
industry); after 1950: recreational risk
[71] 1987 Kauai: 16 cases Swimming in the Waimea river
[72] 1988–
89
Hawaii: 20 confirmed /
172 suspects Kauai: 13
confirmed / 100 suspects
Use of water catchment systems, skin
wounds, handling animal tissues
(especially cattle)
[73] 1992 Oahu: 2 confirmed cases Recreational exposure (falls); not
linked to rats
[74] 1989–
97
7 cases N/A
[75]
[77]
1974–
98
353 confirmed / 752
suspects
Decrease of occupational exposures
over time; increase of recreational
exposures. Animal exposure: dogs
71%, rats 30%. Largest outbreak:
swimming in a river
[76] 1998 Kauai: 2 cases / 5 murine
typhus cases
N/A
[78] 1979–
98
74 confirmed cases N/A
[79] 2002 US Army blood donors,
Oahu: 7/488 (1.4%)
N/A
[80] 2004 Oahu: 2 confirmed / 48
tested
Flooding event on a university campus
[81] 2001–2 54 confirmed /1206 febrile
illness 
N/A
[83] 2011? 1 case Cliff-diving in Maunawili Falls
[82] 1992–
2004
18 confirmed cases Freshwater exposure (83%); 50% of
cases acquired infection in Hawaii,
others were infected in Japan,
Malaysia and other PIs.
[84] 1999–
2008
198 confirmed / 345
suspects
Recreational exposure 45%;
Occupational exposures 44%;
Habitational exposure 11%
N/A: no information available from the study.
The study was conducted during a dengue outbreak.
https://doi.org/10.1371/journal.pntd.0006503.t002
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of recreational exposure (freshwater swimming, hunting, fishing, hiking) [70, 75, 77]. During
1989–2008, the frequency of recreational exposures plateaued while frequency of occupational
exposures seemed to increase (at least for the island of Hawaii). At the same time, a significant
shift in the seasonal occurrence of leptospirosis from the drier summer months to the wetter
winter months was observed [84]. An increase in “habitational risks”, especially gardening at
home, was suspected to be linked to the resurgence of traditional taro farming. Lastly, expo-
sure to feral pigs, although not investigated per se in the epidemiological surveys, was suspected
to be responsible for the changing trend in the infecting serogroup in human cases, shifting
from Icterohaemorrhagiae to Australis.
Animals were first investigated for leptospirosis in Hawaii during the same 1936–1942
investigation targeting humans. Dogs, cats, rats and mongooses were serologically screened
for leptospirosis, and revealed evidence of infection in all three species [66, 88]. Between 1943
and 2009, more animal studies followed, investigating six animal species. Seropositive rats and
mongooses were reported from nine and seven more studies respectively. Evidence of leptospi-
rosis infection was also found in cattle (2/2 studies), mice (6/6), feral swine (1/1) and Hawaiian
monkey seals (1/1). Surprisingly, dogs and cats were never further investigated. The complete
list of animal studies from Hawaii is reported in Table 3.
Hawaii is one of the two places (with New Caledonia) where leptospires were investigated
in the environment. A molecular study from 2011 focused on environmental samples collected
in 22 tropical streams of Oahu near the point at which they discharge to the coastal ocean,
showing evidence of Leptospira in 87 of 88 samples. All of the sequenced amplicons (n = 42)
were characterised as pathogenic Leptospira wolffii.
New Caledonia
Human leptospirosis was first reported in 1954 and 1957. A total of 20 articles from New Cale-
donia were identified. Two seroprevalence studies were conducted in 1985–86 [53, 54], and
the majority of articles were clinical studies (n = 18) including case reports, routine surveil-
lance data, and case investigations. Clinical studies were conducted from 1973 to 2012, with
frequent reports except between 1990–1998, suggesting endemic transmission. Three clinical
studies focused on severe leptospirosis: severe icteric leptospirosis cases with cardiac manifes-
tations [55], the influence of age on the development of severe leptospirosis in children [63],
and risk factors and predictors of severe leptospirosis [64]. The complete list of human lepto-
spirosis studies from New Caledonia is reported in Table 4.
The risk factors for human leptospirosis in New Caledonia varied little between the 1980s
and today. The disease was more frequent among young men and during the wet season. The
main risk factors identified were recreational exposure (fishing and swimming in fresh water,
hunting) and contact with animals, with populations living in rural areas and local tribes being
at highest risk. However, the probable source of infection was difficult to ascertain because of
the multiplicity of potential infecting sources and exposure pathways, and the overlap between
professional and recreational activities [56]. Also, identification of the animal source of lepto-
spires in these (human only) studies was only presumptive as people were frequently exposed
to multiple species, including cattle, pigs, horses, dogs, rats and, less commonly, deer [56, 61].
Eleven studies were published on animal leptospirosis in New Caledonia between 1983 and
2004. Leptospira spp. infection was demonstrated in a wide range of animal hosts, including
cattle (6/6 studies), dogs (6/6), deer (6/6), horses (3/3), pigs (4/5, including one study of feral
pigs), rats (3/3) and cats (2/3). Results on goats largely lacked detail, however one study
reported five seropositive animals. Results on sheep (one study) were inconclusive. The com-
plete list of studies on animal leptospirosis in New Caledonia is reported in Table 5.
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In one study from 2016 in New Caledonia, leptospires were investigated in the environment
[29]. The study focused on environmental samples collected around human cases, showing
that 58% of soil samples were contaminated with pathogenic leptospires.
French Polynesia
The first human leptospirosis cases were reported from Tahiti in the 1950s [31]. Two serologi-
cal surveys in the general population were conducted in French Polynesia: one in Tahiti in
1970–71 [34] found a seroprevalence of 29.5%, and another in Marquesas in 1981 [39] where a
lower seroprevalence (9.5%) was found. In addition, 20 clinical studies from 1952 to 2015 pro-
vided evidence of human leptospirosis, suggesting endemic transmission throughout the
archipelago. Available reports generally covered the whole of French Polynesia, a vast archipel-
ago of 118 islands and atolls, because diagnostic laboratories received samples from clinically-
suspected cases from all islands, but a few studies were dedicated to specific Islands, i.e. Mar-
quesas [5, 39, 46] and Raiatea [5, 46]. The complete list of human studies from French Polyne-
sia is reported in Table 6.
Table 3. Summary of publications reporting animal leptospirosis in Hawaii, 1947–2017.
Citation Study years Animal species Test N Positive cases (%)
[88] N/A Dogs S 100 39 (39%)
[66] 1936–42 Cats S 100 0
Rats DF 447 18 (4%)
Mongooses DF 12 4 (33%)
[67] 1943 Rats S, DF 96 17.2% (Kohala district), 31.3% (Olaa district)
Mongooses S, DF 86 20% (Kohala district), 23% (Olaa district)
[89] 1950s-60s Rats, mice, mongooses S 1238 558 (45%)
[90] 1959–61 Rats (RR, RN, RE) S 1705 587 (34%)
Mice S 170 98 (58%)
Mongooses S 152 49 (32%)
[91] 1970–73 Rats (RR, RN, RE) S, DF, IC 819 201 (25%)
Mice S, DF, IC 26 5 (19%)
Mongooses S, DF, IC 282 65 (23%)
[92] 1969–74 Rats (RR, RN, RE) S, IC 305 50% RN, 55% RR, 34% RE
Mice S, IC 53 33%
Mongooses S, IC 180 23%
[93] 1969–73 Rats (RR, RN, RE) S 2389 722 (30%)
Mice S 95 41 (43%)
Mongooses S 473 136 (29%)
[71] 1987 Rats DF 14 0
Cattle S 139 89 (64%)
[94] N/A Cattle S, IC - 1 isolation from kidney
[73] 1992 Rats (RR, RN, RE) S, IC 85 4/77 RR, 1/2 RN, 0/6 RE
[76] 1992–98 Mongooses, rats, mice S, IC 12501 2391 (19%)
[95] 1997–2001 Hawaiian monkey seals S 308 19 (6%)
[96] 1990–2003 Rats, mice S, DF, IC 15171 2766 (18.2%)
[97] 2007–2009 Feral swine S 804 33.8%
N/A: information unavailable from the study; N: number of animals tested; RR: Rattus rattus; RN: Rattus norvegicus;
RE: Rattus exulans; S: serology test; DF: microscopic examination of kidney tissues with a dark field microscope; IC:
isolation by culture.
https://doi.org/10.1371/journal.pntd.0006503.t003
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Table 4. Summary of publications reporting human leptospirosis in New Caledonia, 1947–2017.
Citation Study
years
Case reports Seroprevalence studies Exposure/risk factors
[32] 1954, 1957 7 confirmed cases N/A
[36] 1974–79 24 confirmed cases N/A
[49] 1973–80 32 cases N/A
[50] 1973–80 37 confirmed / 286
suspects
Possible drivers: Poor hygiene, rivers
[51] 1973–81 39 confirmed cases
1981: 5 cases (1
infected in Vanuatu)
Possible exposure: Streams, occupational
activities
[52] 1983–85 57 cases Living in rural areas, in tribes
[53] 1985–86 193 cases Around cases: 63/210 Cases: 72% live in flood plains
Occupational risk: 124/
669
Around cases: farmers most at risk
Control population: 26/
260
Occupational risk: farmers most at risk
[54] 1985–86 La Ne´ra: 60 cases Around cases:
Ne´ra = 16/41;
Coule´e = 5/20
Cases: 85% live in a muddy place; 95% in
frequent contact with rivers
La Coule´e: 26 cases Occupational risk:
Ne´ra = 16/41;
Coule´e = 16/93
[55] 1983–85 57 cases, 15 with
cardiac symptoms
N/A
[42] 1987 46 cases N/A
[56] 1989–93 192 confirmed cases
Peak in 1990 (51
cases)
Temporality: 4-fold increase in March
65.9% cases: Melanesian leading a tribal
lifestyle; subsistence farming
Recreational risks: bathing in running
fresh water, fishing, hunting
[57] 1989 144 confirmed cases Exposure: ditch or river water; living in a
rural area. Contacts with rats, dogs
[58] 1989–90 Bourail: 78
confirmed cases
Exposure: Swimming, poor hygiene,
hunting, fishing, contact with animals
[60] 1989–2001 156 cases
[59] 2005 37 confirmed and 3
probable / 1059
suspects
Exposure: Swimming, hunting, fishing,
contact with animals
[61] 2001–05 239 confirmed / 6690
suspects
Contacts with animals, recreational
activities
[62] 2008 Outbreak: 135
confirmed cases
Suspected driver: heavy rainfalls associated
with floods. Exposure: Contact with
animals (OR>2), swimming, fishing,
hunting (OR>3)
[63] 2006–12 60 cases under 18yo Age-dependant association with severity of
leptospirosis
[64] 2008–11 72 severe
leptospirosis / 306
cases
Delay in diagnosis, tabacco use, infection
by L. interrogans Icterohaemorragiae
[65] 2000–12 731 confirmed and
432 probable/ 1163
suspects
SST anomaly, rainfall, temperature
N/A: information unavailable from the study.
https://doi.org/10.1371/journal.pntd.0006503.t004
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Three clinical studies included case investigations (through questionnaires) that aimed to
identify risk factors associated with human leptospirosis (2006–2010), and important factors
common between the studies included contact with rats or domestic animals, walking barefoot
in water or mud, swimming in rivers, gardening, and occupational risks (working in piggeries,
Table 5. Summary of publications reporting animal leptospirosis in New Caledonia, 1947–2017. For study [54]
the number of tested animals ‘N’ is provided separately for the two areas of interest, i.e. La Ne´ra basin first and La Cou-
le´e basin then. Studies [60] and [98] targeted positive animals only, so ‘N’ equals ‘positive cases’.
Citation Study years Animal species Test N Positive cases (%)
[99] 1982–83 Cattle S 136 84 (61.8%) seropositive
Dogs S 38 12 (31.6%) seropositive
Horses S 25 13 (52%) seropositive
Pigs S 43 10 (23.3%) seropositive
Sheep/goats S 2 1 (suspected) seropositive
[100] 1986 Cattle S 5 5 seropositive
[53]
Grande Terre and
Islands
1985–86 Rats (RR, RN, RE) S, DF, IC 18 11 (61.1%) seropositive
Cattle S, DF, IC 70 69 (98.7%) seropositive
Pigs S, DF, IC 36 21 (58.3%) seropositive
Horses S, DF, IC 18 9 (50%) seropositive
Goats S, DF, IC 13 N/A
Dogs S, DF, IC 81 48 (59.3%) seropositive
Cats S, DF, IC 12 NA
[54]
La Ne´ra + La Coule´e
1985–86 Rats (RR, RN, RE) S 12 + 4 8 + 3 seropositive
Cattle S 15 + 0 15 seropositive
Pigs S 14 + 0 ?
Horses S 4 + 0 ?
Goats S 9 + 4 1 + 2 seropositive
Dogs S 46 + 7 29 + 2 seropositive
Cats S 6 + 5 0 + 1 seropositive
Deer S 1 + 0 1 seropositive
[101] 1984 Cattle S 350 58.3% seropositive
[60] 1989–2001 Dogs TY 1 1
Pigs TY 7 7
Deer TY 5 5
[98] 2010 Introduced deer TY 12 12
[102]
Poster summary
Introduced deer yes
Rats (same as [103]) yes
[103] 2008–10 Rats, mice (Bourail
area)
MT 210 56 (26.7%) renal carriage
[104] 2009 Cattle S 30 43% seropositive
Deer S 29 72% seropositive
Horses S 25 80% seropositive
Dogs S 51 43% seropositive
Cats S 8 100% seropositive
[105] 2013 Dogs (urban + rural) S, MT 95 30.8% seropositive; 4.4% renal
carriage
Pigs (feral + farmed) MT, TY 94 + 138 6.4% (feral); 10.2% (farmed)
Deer (feral + farmed) MT, TY 85 + 107 13.02%
N/A: information unavailable from the study; N: number of animals tested; RR: Rattus rattus; RN: Rattus norvegicus;
RE: Rattus exulans; S: serology test; DF: microscopic examination of tissues with a dark field microscope; IC: isolation
by culture; MT: molecular testing (PCR); TY: molecular typing.
https://doi.org/10.1371/journal.pntd.0006503.t005
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Table 6. Summary of publications reporting human leptospirosis in French Polynesia, 1947–2017.
Citation Study
years
Case reports Seroprevalence
studies
Exposure/risk factors
[31] 1952–53 Tahiti: 2 cases Rats trapped in the same suburbs are infected;
pigs and dogs might be
[32] 1952–57 7 confirmed + 4
probable / 35 suspects
N/A
[33] 1969–70 Tahiti: 36 cases N/A
[34] 1970–71 Tahiti: 224/759
(29.5%)
N/A
[35] 1955–68
1969-72
22 confirmed cases
66 confirmed cases
Possible drivers: favorable climatic conditions;
flood-risk areas; lots of rats and roaming dogs
[36] 1970–79 77 severe cases N/A
[37] 1975–80 43 confirmed / 60
hospitalized
Occupational risk (16), rodents around
(most); 50% of cases don’t swim in rivers
[38] 1975–80 60 cases Thrombocytopenia (16), renal failure (15),
both (10)
[39] 1981 Marquesas: 24/253
(9.5%)
Exposure: contacts with dogs, rats; walking
bare-foot
[40] 1983 11 cases N/A
[41] 1985–87 Tahiti: 6 cases with
pulmonary
complications
N/A
[42] 1987 36 cases N/A
[43] 1984–90 114 confirmed / 120
hospitalized
Exposure: living in rural or semi-rural areas in
contact with livestock (pigs)
[44] 1994–2000 360 confirmed cases /
2525 suspects
N/A
[45] 2004–05? Tahiti: 71 severe cases Severe outcome linked to hypotension,
oliguria, abnormal chest auscultation at the
first examination
[5] 2003–05 Marquesas: 13
confirmed /47
suspects
Marquesas: hunting (75% cases)
Raiatea: 16 confirmed
/68 suspects
Raiatea: bathing if freshwater (64% cases)
[46] 2004–05 Marquesas: 13
confirmed /47
suspects
Possible drivers: Contact with dogs, hunting
in Marquesas; contacts with rats in Raiatea
Raiatea: 20 confirmed
/66 suspects
[47] 2006–08 165 confirmed cases
+ 107 probable
Swimming in river (30%), farmers (22%),
contact with rats (24%) dogs (21%) or cats
(17%), walking barefoot (21%), gardening
(18%)
[106] 2010 81 confirmed cases Contact with rats (40%) or domestic animal
(60%), walking barefoot in water or mud
(77%); swimming in rivers (43%), gardening
(50%); working in piggeries (17.5%), farmer
(52%)
[107] 2006–10 502 cases, 100
serotyped
Contact with rats (34%) or domestic animal
(60%), walking barefoot in water or mud
(33%); swimming in rivers (35%), gardening
(30%); working in piggeries (14%), farmer
(29%)
[24] 2014–15 2 cases (co-infection
with chikungunya)
N/A
(Continued)
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farming) [47, 106, 107]. In Marquesas, hunting and contact with dogs have been reported as
possible sources of infection [5, 46]. Risk factors in French Polynesia were mostly recreational
rather than occupational, but potential infecting sources were numerous.
Only three studies investigated animal leptospirosis in French Polynesia. The first study
(1952–53) investigated renal carriage in rats from Tahiti by experimental infection of guinea
pigs with crushed rat kidneys; four guinea pigs became icteric [31]. The second was a seroprev-
alence study (1981–86) targeting four host species from Tahiti, and cattle from both Tahiti and
Marquesas [108]. Positive serology results were found in 15.5% (23/148) of cattle, 32.2% (37/
115) of pigs, and all five horses tested. Serology results were not detailed by island, but only
seven tested cattle originated from Marquesas. The two sheep and twelve dogs tested were
found to be seronegative. The last study investigated animal leptospirosis in dogs, pigs and rats
from Tahiti [48]. Renal carriage of pathogenic leptospires was demonstrated from 26.5% (48/
181) of farmed pigs, 20.4% (23/113) of rats, and four sick dogs.
Fiji
The first study reporting human leptospirosis in Fiji was published in 1978 [109], describing
240 cases between 1969 and 1977. Since then, two community-based seroprevalence studies
were published [110, 111], as well as five studies reporting clinical cases [5, 112–115]. The first
seroprevalence study in the 1980s identified 264 seropositive out of 300 healthy volunteers
(88%) from a rural area in the main island of Viti Levu [110]. A second seroprevalence study
was conducted in 2013 and included 2,152 healthy individuals from 81 communities on the
three main islands of Fiji, of whom 19.4% were seropositive [111]. Risk factors associated with
infection included living in villages (OR 1.64), lack of treated water at home (OR 1.52), work-
ing outdoors (1.64), living in rural areas (OR 1.43), high poverty rate (OR 1.74), living<100m
from a major river (OR 1.41), pigs in the community (OR 1.54), high cattle density in the dis-
trict (OR 1.04 per head/km2) and high maximum rainfall in the wettest month. Using the data
from the 2013 seroprevalence study (which included questionnaire data about contact with
animals as well as livestock data from the Fiji Ministry of Agriculture), a third study [116]
showed significant heterogeneity in the relative importance of animal species in leptospirosis
transmission in different ethnic groups and residential settings.
Five studies have been published on animal leptospirosis in Fiji [113, 117–120], exploring a
wide range of host species, including dogs, goats, mongooses, cattle, pigs, rats, sheep, mice,
horses and cats. Except for cats (only three animals tested), the studies identified seropositive
animals in all species that were tested. Thus, Leptospira infection seems common in multiple
animal species in Fiji.
Papua New Guinea
Studies on human leptospirosis in Papua New Guinea (PNG) were published between 1955
and 1968 [121–124], including three seroprevalence studies targeting healthy volunteers,
Table 6. (Continued)
Citation Study
years
Case reports Seroprevalence
studies
Exposure/risk factors
[48] 2014–15 44 confirmed cases Possible risk factors: rats and dogs (as they
share common types of leptospires with
human cases)
N/A: information unavailable from the study.
https://doi.org/10.1371/journal.pntd.0006503.t006
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showing high seroprevalence of 53.0% to 57.5%, with Australis and Hebdomadis the most
common serogroups. One study explored risk factors for human infections and found that lep-
tospirosis in PNG was common in both males and females, and in both adults and children,
reflecting high risk in the whole population from shared occupational, domestic, and other
environmental exposures [123]. People have close contact with domestic animals, particularly
dogs and pigs, as well as native fauna in gardens and uncleared areas surrounding the villages.
Rats were suspected to be of less importance compared to other animal species because human
studies in PNG found that serogroup Icterohaemorrhagiae (commonly associated with
rodents) was relatively uncommon [122, 125].
Leptospira infection in animals was explored in the 1960s and 1970s, with seven publica-
tions exploring infection in rats, cattle, dogs, pigs, goats and marsupial bandicoots [122, 123,
125–129]. Seropositive animals were identified from all tested species, but sample size was
small for bandicoots (n = 5). After the 1970s, no further studies were published until a sero-
prevalence study investigated cattle (n = 1,452) and pigs (n = 326) in 2004, and dogs and live-
stock in 2006 (111 cattle, 69 pigs, 22 dogs, 15 horses) [130]. Seropositive animals were
identified from all species, but seroprevalence was low in dogs (1/22 in 2006) and pigs (0/362
in 2004, 1/69 in 2006).
Guam
The first study published in 1974 identified three seropositive stray dogs out of 180 tested
(1.7% seroprevalence) [131]. More recent studies investigated cattle (n = 34) and pigs (n = 52)
in 1999 [132], and feral pigs (n = 46) in 2015 [133]. All livestock tested seronegative but the
seroprevalence in feral pigs was 23.9%.
The first human clinical study was published in 1998, describing two human leptospirosis
cases with pancreatitis [74]. Three human clinical studies in the 2000s reported sporadic cases
only [5, 74, 134, 135]. In addition, two leptospirosis cases reported in Hawaii for the period
1999–2008 were suspected to have been acquired in Guam [84]. One mixed study included
both clinical data and a seroprevalence study conducted following an outbreak that occurred
after an outdoor multisport athletic event: out of 46 participants surveyed, 21 reported being ill
and three of them were confirmed with recent leptospirosis infections [136]. Reported expo-
sures were often recreational activities involving swimming in fresh water or waterfalls, but
water buffaloes were also reported as a suspected source of contamination.
Wallis and Futuna
No seroprevalence study has been conducted in Wallis and Futuna. A multicentre survey of
suspect clinical cases recruited by general practitioners conducted in 2003–2005 identified 3
cases out of 14 (21%) and 31 cases out of 71 (44%) in Wallis Island and Futuna Island respec-
tively [5]. Another clinical study conducted in 2005 identified one case in Wallis and 21 cases
in Futuna [137], and reported some exposure information: one case swam in a river few days
before the occurrence of the disease, and all the other cases were involved in breeding pigs (at
home for the Futuna cases, at work in a pig farm for the one Wallis case). A third study con-
ducted over the period 2004–2014 reported 382 cases in Futuna, with a peak incidence in 2008
[7]. Serogroup Australis was predominant until 2007, when Icterohaemorrhagiae became the
most common. Despite similar cultural and socio-economical patterns between the islands,
human leptospirosis was considered endemic in Futuna while it only occurred sporadically in
Wallis.
Three studies focused on animal leptospirosis in Wallis and Futuna. A first study focusing on
livestock only reported the detection of specific Leptospira serogroups in pigs, with no prevalence
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provided [138]. A seroprevalence study was conducted in the 1990s on different animal species:
14% (12/88) of pigs were found to be seropositive in 1985, and 33% (54/163) in 1997 but a wider
range of serogroups was tested in 1997. In 1998, two dogs out of 10 and three horses out of six
also tested seropositive, while all 11 goats tested were seronegative [138, 139]. In 2008–2012, Lep-
tospira prevalence in three rat species was investigated [140]. Renal carriage of Leptospira interro-
gans was confirmed in 84 rats out of 286 in Futuna (36.4% Rattus rattus, 42.8% Rattus norvegicus
and 18.8% Rattus exulans), while only one R. exulans out of 56 rats (1.8%) was positive in Wallis;
15 rats were found negative in the uninhabited island of Alofi, 2 km from Futuna.
Risk factors associated with human leptospirosis have not been formally investigated, but
rodents in Futuna have a much higher Leptospira carriage rate than on Wallis. It has been
hypothesised that this variation could be explained by differences in taro farming practices;
people on Wallis irrigate their fields by ditches, while those on Futuna flood their fields. This
practice in Futuna might facilitate the spread of Leptospira among rats and subsequently to
humans [140].
American Samoa
Human leptospirosis was first investigated in American Samoa in 1948 [141]; ten patients hos-
pitalised for jaundice were tested, but none were seropositive against four Leptospira ser-
ogroups. Thirty patients hospitalised for reasons other than jaundice were also tested, and
three were found to be seropositive for serogroup Australis. Leptospirosis cases were later
occasionally reported, including three cases of co-infection with dengue in 2008 [142] and one
severe case in 2011 of a 15 year old boy who frequently slept in the rainforest and had recently
waded through freshwater [143].
Four community-based seroprevalence studies were conducted in American Samoa. Two
studies reported seroprevalence rates of 17% in 2004 (n = 341) [144] and 15.5% in 2010
(n = 807) [145]. Australis was the main serogroup in 2004 (71%) while Hebdomadis, Australis
and Pyrogenes were the most common serogroups in 2010. The 2010 survey found that out-
door occupation (OR = 3.25), piggeries around the house (OR = 2.63) and recreational expo-
sure (swimming at beach OR = 2.01, fishing OR = 1.78) were significantly associated with
seropositivity, but infections with each of the three main serogroups were associated with dif-
ferent behavioural and environmental exposures [145]. A third study compared the serogroups
between the 2004 and 2010 surveys [146] and showed epidemiological evidence of serogroup
emergence, possibly as a result of ecological and environmental change. The fourth study pro-
duced a predictive risk map using environmental variables from 2010 study and demonstrated
the importance of environmental drivers of transmission [147].
Two studies focused on animal leptospirosis. Renal carriage of leptospires by rats was exam-
ined on Tutuila Island in 1948; out of 126 individuals from four rat species trapped, 24 (19%)
Rattus norvegicus kidney tissues stained by silver precipitation technique were found positive
under microscopic examination [141]. One out of twelve dogs was also found seropositive by
MAT. A more recent study published in 2005 reported data ‘from animal studies and litera-
ture’ (with no date specified) showing seropositive results from pigs, rats, dogs and cattle
[135]. The authors suggested that, even though the animal studies were not conducted at the
same time as the human studies (2004), it appeared that Australis was the most common ser-
ogroup infecting people, and pigs were the most likely reservoir hosts.
Federated States of Micronesia
Seven clinical studies reported information about human leptospirosis in the Federated States
of Micronesia (FSM), which consists of the four states of Yap, Chuuk, Kosrae and Pohnpei in
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the Northwestern Pacific Ocean. In 1989–1997, eight confirmed leptospirosis cases identified
in Hawaii were acquired from Kosrae and Pohnpei [74], and from 1999–2008 one reported
case in Hawaii was acquired from FSM [84]. A multi-centre survey of patients with suspected
leptospirosis conducted in 2003–2005 reported no seropositive case from Yap (0/1 suspected)
or Pohnpei (0/27 suspected) [5]. In 2010, an investigation of 10 febrile patients in Chuuk
revealed two confirmed cases of leptospirosis [148]. In 2011, a hospital-based survey con-
ducted in Pohnpei on 54 patients presenting with undifferentiated fever found that 20.4%
showed serologic evidence of acute infection by MAT [149]. In 2012 in Yap, 172 patients with
suspected dengue were investigated by qPCR and five (2.9%) were confirmed as acute leptospi-
rosis infections [150]. Lastly, one study investigated the health risks associated with climate
change in FSM using a time series distribution of monthly leptospirosis outpatient cases in
Pohnpei. This study was based on hospital records and is assumed to represent close to all of
the reported cases [151]. Taken together, those studies suggest that leptospirosis is endemic in
FSM.
Rats were the first animal species to be investigated in 1947, but microscopic examination
of kidney tissues stained by silver precipitation technique did not reveal any leptospires from
28 rats trapped in Chuuk and Pohnpei [152]. However, a seroprevalence study conducted in
1995–1996 on pigs (in four states), dogs (Pohnpei, Chuuk) and rats of three species (Pohnpei,
Chuuk, Yap) showed positive results from all species [153].
Solomon Islands
No papers on human leptospirosis were identified from the Solomon Islands, and only three
papers on animal leptospirosis have been published. Between 1967 and 1977, a large veterinary
survey investigated cattle diseases from all the cattle herds listed in 1967 (165 herds with a total
of 8,930 cattle) plus some of the 650 herds established after 1967 [86]. For leptospirosis, only
the female cattle over one year of age were tested, of which 62 were found seropositive. In
1985, pigs were reported positive with serogroup Pomona, but detailed results were not avail-
able [154, 155]. A seroprevalence study conducted in 1998 reported that 83% of 226 cattle, 12%
of 298 pigs, 16% of 63 goats, and 71% of 31 horses tested were seropositive by MAT [155].
Vanuatu
Only sporadic cases of human leptospirosis have been reported in Vanuatu in the 1990s [156,
157] and the 2000s [5]. No human seroprevalence studies have been conducted. Two cases in
travellers returning from Vanuatu were also reported in New Caledonia [51] and Australia
[158]. The latter swam in a river in Vanuatu with an injured foot, and developed a fatal illness
with acute renal failure, jaundice, respiratory failure, myocarditis and rhabdomyolysis.
During an extensive survey of livestock diseases conducted between 1971 and 1981
throughout the Vanuatu archipelago, 6,719 cattle from 131 herds were investigated by MAT;
92 cattle (1.4%) were found positive [159].
Palau
Following the presentation of three cases of Weil’s disease in 2000, 171 patients presenting
with a ‘viral syndrome’ were investigated in Palau, of whom seven were serologically con-
firmed as leptospirosis [160]. Over the period 2000–2006, the disease surveillance system
recorded 81 cases, all living in the most populated areas of the country [161]. In 2003–2005, a
multi-centre survey of patients with clinically suspected leptospirosis reported one seropositive
out of eight tested [5]. In 2014, two Japanese travellers developed leptospirosis after returning
from Palau; the suspected exposure was swimming in Ngardmau falls [15].
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Cattle (n = 20), goats (n = 7) and pigs (n = 55) were serologically investigated by MAT
between 1993 and 1996 in Palau [162]. All three investigated species were found seropositive
for Leptospira, i.e. 9 cattle (45%), 3 goats (43%) and 22 pigs (40%).
Other Pacific Islands
In Tonga, a multi-centre survey of clinically suspected cases was conducted in 2003–2005; four
patients were tested by PCR or MAT but none were confirmed as leptospirosis [5]. Cattle
(n = 171) and pigs (n = 244) from different Tongan islands (Tongatapu, ’Eua, Ha’apai, Vava’u)
were serologically investigated by MAT between 1992 and 1994 [163]. Seroprevalence varied
between the islands, from 19.6% to 45.0% in cattle, and from 5.0% to 16.7% in pigs.
In the Commonwealth of the Northern Mariana Islands (CNMI), leptospirosis has been
reported as endemic, but our search retrieved only one study; in 2000–2001, 10 cases of lepto-
spirosis were reported in Saipan, of which eight were severe, and three were fatal [164]. In
none of the cases was laboratory diagnosis available to the medical staff until weeks after
patient was hospitalized or had died. Case reports available for four of the patients identified
possible exposures as swimming in freshwater, cleaning out roadside sewers after a tropical
storm, slaughtering pigs, and occupational gardening.
In 1989–1997, one confirmed leptospirosis case identified in Hawaii was acquired from the
Marshall Islands [74].
For the remaining Pacific Islands, our search retrieved no studies on human leptospirosis,
but few animal studies were available for Easter Island, Kiribati, Niue, Cook Islands, Samoa
and Tokelau. The results are summarised in Table 7.
Discussion
This systematic review is the first to synthesize and compile data on the epidemiology of
human leptospirosis and pathogenic Leptospira spp. infection in animals in the PIs.
Table 7. Summary of publications reporting animal leptospirosis in the Pacific Islands for which no studies on
human leptospirosis were reported, 1947–2017.
Citation PICTs Study years Host N Confirmed cases (%)
[165] Easter Island 1946–65 Cattle 57 46 low-grade reactions with MAT
Sheep 146 0
Pigs 13 0
[166] Kiribati 1975–80 Pigs 172 0
1985 Goats 51 8 (15.7%) seropositive
1992–94 Pigs 193 6 (3.1%) seropositive
[167] Niue 1992–94 Cattle 60 Inconclusive serology
Pigs 60 Inconclusive serology
[168] Cook Islands
(Raratonga)
1982–83 Cattle 48 3 (6.3%) seropositive
Pigs 60 1 positive, 6 inconclusive (11.7%)
[141] Samoa 1948? Rats 36 8 (22.2%) renal carriage
[169] Samoa ? Cattle 629 414 (65.8%) seropositive
Pigs 108 27 (25%) seropositive
[170] Samoa 1997 Cattle 316 125 (40%) seropositive
Horses 63 28 (44%) seropositive
Pigs 161 37 (23%) seropositive
[171] Tokelau 1998 Pigs 88 3 (3.4%) seropositive
https://doi.org/10.1371/journal.pntd.0006503.t007
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Considering the limited population and economic resources in those mostly small and isolated
islands, the number of studies retrieved was impressive (n = 148). Overall, the systematic
review demonstrates that leptospirosis is an important cause of acute febrile illness across the
PIs, with evidence of human disease demonstrated in 13 of 14 PIs where investigations have
been conducted. Community-based seroprevalence studies were conducted in seven PIs and
provided heterogeneous results, with prevalence ranging from 10% to 88%. Taken together,
these findings reflect the public health importance of leptospirosis in the region, and corrobo-
rate recent estimates of very high disease burden in Oceania [3]. A wide range of domestic and
wildlife species (n = 13 when counting rats as a single species) from across the PIs showed evi-
dence of present and/or past infection with Leptospira. In some PIs, infected animals were
mainly livestock (cattle and pigs in particular), indicating the potentially important role of
non-rodent reservoir species in human infections, especially in islands where backyard subsis-
tence livestock are common. However, rats were investigated in fewer studies and less islands
than livestock, even in islands where serogroup Icterohaemorrhagiae was identified from
human cases (e.g. Palau).
Even though many studies on human leptospirosis in the PIs were retrieved, these studies
probably under-estimate the true burden as leptospirosis is thought to be under-reported glob-
ally, particularly in developing countries such as the majority of PIs. Several studies included
in our review were conducted during outbreaks of dengue [81, 142, 150], chikungunya [24] or
murine typhus [76], and coincidentally identified leptospirosis cases that might otherwise have
remained undetected. On the contrary, the co-circulation of different infectious diseases shar-
ing similar clinical presentation in the PIs might lead to leptospirosis under-diagnosis, some-
times resulting in a fatal outcome [24]. In the reviewed human clinical studies, diagnosis for
leptospirosis often occurred very late, in already hospitalised (n = 21 studies where hospitalisa-
tion is specified) or even deceased patients [164]. A case report from American Samoa
highlighted some of the leptospirosis diagnostic challenges faced by clinicians in the PIs [143].
There is still a need to raise awareness and to reinforce diagnostic capabilities for leptospirosis
in the PIs. These have to go hand in hand with better agreement about the use of diagnostic
tools and interpretation of the results. The development of clinical guidelines for the manage-
ment of febrile patients with suspected leptospirosis should be a priority.
Serological studies suggested a wide variety of Leptospira serogroups (n = 21) in humans
and animals across the PIs, including common as well as rare serogroups. Reported serogroups
varied between PIs, between humans and animals, and between animal species. Across the PIs,
seropositive animal hosts were reported for all the serogroups detected in human cases. How-
ever, it was difficult to make serogroup links between animals and humans because data were
reported from multiple studies with variable study designs. Also, MAT results were difficult to
interpret because of the intrinsic limitations of the test, as well as the heterogeneity in data
quality between the studies. MAT has limited sensitivity, especially with early acute-phase
specimens, and with chronically infected animals (reservoirs) that may be serologically nega-
tive even while shedding the bacteria in their urine [173]. Also, MAT results may vary depend-
ing on subjective interpretation by laboratory personnel and the panel of serovars used [2].
Interpretation is further complicated by the high degree of cross-reactions that occurs between
Leptospira of the same serogroup or even between serogroups [173]. Apart from those intrinsic
limitations, many studies included in our review were classified as “weak evidence” because
they did not comply with our case definition and/or provide the minimal information required
to assess the quality of the results. Even in studies complying with our case definition, some
MAT results were still overstated. For example, one study from New Caledonia [57] reported 12
different serogroups in severe cases identified in 1989, while studies using Leptospira isolates or
genotyping techniques have provided evidence that only six serogroups have been responsible
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for human cases in New Caledonia [60, 98]. Therefore, tables of serology results provided in
this review (Table 1 and S2 Table) should be taken as summaries of the reports from the studies,
but interpreted with great caution. To ensure a proper quality assessment of the results and
accurate interpretation, it is crucial that in the future MAT results are reported in detail, espe-
cially providing information regarding the panel of serovars used, MAT titres, and detailed and
appropriate case definition criteria. In cases where serology is expected to be of poor sensitivity,
the use of molecular methods might be more appropriate. In our review, a limited number of
studies relied on a molecular diagnosis (n = 14 in animals; n = 15 in humans).
Studies including both animal and clinical data were uncommon (n = 13 in 11 PIs) in this
review. Also, molecular characterization of Leptospira spp. diversity that allows human Leptos-
pira infection to be traced back to the probable source of contamination [172] was attempted
in very few studies. When Leptospira infection was investigated in separate studies for animals
and humans in a same PI, it was generally not possible to link the results, for example because
of a time gap between animal and human studies, and/or different study designs, and/or the
use of different MAT panels. In some PIs, human leptospirosis was not investigated, even
though Leptospira infection was demonstrated in animals, i.e. in the Solomon Islands, Cook
Islands, Kiribati, Niue, Tokelau, Samoa, and to a lesser extent Tonga where only four suspect
human cases were tested. Also, we retrieved livestock studies from 19 PIs while rodent studies
were available from only eight of these 19 PIs, which might bias our understanding of leptospi-
rosis infection in humans in the PIs.
This review identified common behavioural risk factors and environmental drivers for lep-
tospirosis infection across the region. Environmental drivers were mostly climate-related
(flooding, extreme events), while individual risk factors included backyard subsistence live-
stock, farming, lifestyle (walking bare-foot, fishing, hunting), contact with animals and contact
with fresh water sources (recreational use, washing laundry). Our review only identified a few
epidemiological surveys that conducted robust statistical analyses of risk factors associated
with human leptospirosis. Many studies reported some “possible drivers” of infection, or some
“possible exposure” but the hypotheses were rarely properly evaluated. Even where surveys on
clinical cases were conducted with detailed questionnaires, the probable source of infection
was difficult to ascertain because of the multiplicity of potential infecting exposures (e.g. peo-
ple who have been in contact with rats and pigs and dogs, and have been swimming in fresh
water), the overlapping of professional and recreational activities and the lack of a comparator
or control group.
Leptospirosis as a human disease is the result of complex interactions between humans, ani-
mal reservoirs/carriers, and the environment where the bacteria can survive. Our findings sug-
gest that the major animal reservoirs of human-infecting leptospires may vary across the PIs,
but that livestock (especially cattle and pigs), dogs and rodents may all play important roles in
disease transmission to humans. However, intra-island heterogeneity has not been explored.
In Fiji, the difference between habitats has been specifically investigated, showing that the
relative importance of animal species in human infections varied between urban, peri-urban
and rural settings [111]. We also showed a wide heterogeneity of leptospirosis serogroups and
individual risk factors within and between islands. Combined with the already discussed limi-
tations of the MAT and the limited number of studies combining animal, human and environ-
mental investigations, overall the epidemiology of the disease is still unclear for most of the
PIs.
As already advocated in other studies [174, 175], eco-epidemiological studies following an
integrated “One Health” approach are needed to understand the exposure pathways for lepto-
spirosis in humans, including the specific role and relative importance of each animal species
in different environmental settings. Future studies should further explore how disease
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transmission to humans is influenced by the complex interactions between humans, animals,
and the environment, including interactions within as well as between ecological scales. Also,
better integration of environmental studies (only two in our search), inclusion of health eco-
nomics evaluations and application of novel epidemiological methods such as mathematical
modelling would be valuable next steps. This is crucial in a context where climate change,
increased risk of flooding, population growth, urbanization, loss of biodiversity and agricul-
tural intensification could individually, or possibly synergistically, lead to further increases in
the burden of human leptospirosis in the Pacific. In the future, guidelines for a proper frame-
work for leptospirosis research may help to improve our understanding of local epidemiology
and complex transmission dynamics of leptospirosis worldwide.
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